Agena Biosciences, Manchester University Partner on Pharmacogenomics Education

Young man working at home
Young man working at home

Genetic testing company Agena Bioscience has announced a partnership with Manchester University (MU) to broaden awareness and access to pharmacogenomic (PGx) educational resources. MU is a leading institution providing innovative PGx educational programs within healthcare and laboratory sciences.

 

Under the terms of the partnership Agena Bioscience will promote to its customers the established MU PGx programs, including the Graduate Certificate in PGx or Master of Science in PGx degree. Both programs are fully online and delivered by Manchester University faculty. The PGx Graduate Certificate is comprised of five courses aimed at providing in-depth education to enhance the clinical capabilities of health care professionals. The MU Master of Science in PGx program provides unparalleled depth and breadth in pharmacogenomics, covering human genetics, bioinformatics, pharmacokinetics, and more.

“Our relationship with Agena stems from the mutual goal of expanding the awareness of pharmacogenetic testing and its importance to the future of precision medicine. We believe that pharmacogenomics will increasingly enable physicians and other clinicians to prescribe the right dose of the right medicine at the right time, which ultimately leads to better healthcare outcomes. Our educational programs are aimed at producing applied scientists with opportunities for careers in the PGx laboratory industry, translational companies, and healthcare systems,” stated W. Thomas Smith, Pharm.D., J.D., Dean of Pharmacy and Graduate Life Sciences at Manchester University. “We are thrilled to partner with Agena Bioscience, an industry leader in the PGx space, to offer our programs to a broader audience.”

Peter Dansky, president of Agena Bioscience, expressed enthusiasm about this development, stating, “As a leading provider of PGx testing tools, we are proud to work with Manchester University to provide unique offerings that address our customers’ desire to increase their knowledge and proficiency in pharmacogenomics. This partnership highlights our commitment to improving healthcare through precision medicine.”

This site uses Akismet to reduce spam. Learn how your comment data is processed.